title: Cough is common in children prescribed converting enzyme inhibitors.
authors.forename: R O
authors.initials: RO
authors.lastname: von Vigier
authors.forename: S
authors.initials: S
authors.lastname: Mozzettini
authors.forename: A C
authors.initials: AC
authors.lastname: Truttmann
authors.forename: P
authors.initials: P
authors.lastname: Meregalli
authors.forename: G P
authors.initials: GP
authors.lastname: Ramelli
authors.forename: M G
authors.initials: MG
authors.lastname: Bianchetti
mesh_terms: D000293:Adolescent; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D002216:Captopril / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003371:Cough / Q000139:chemically induced*; D004656:Enalapril / Q000009:adverse effects; D005260:Female; D006801:Humans; D007223:Infant; D007674:Kidney Diseases / Q000188:drug therapy; D008297:Male; D020913:Perindopril / Q000009:adverse effects; D013997:Time Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril; D002216:Captopril; D020913:Perindopril